| Product Code: ETC11944707 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The import shipments of endoscopy devices for obesity, type II diabetes, and NASH in Mauritius continue to show promising growth potential, with a strong CAGR of 12.89% from 2020 to 2024. Despite a slight dip in growth rate from 2023 to 2024 (-2.66%), the market remains dynamic. Top exporting countries include China, India, USA, Metropolitan France, and South Africa, indicating a diverse range of sources for these specialized medical devices. With low concentration levels (HHI) in 2024, the market in Mauritius for endoscopy devices in these specific healthcare areas appears to be competitive and steadily expanding.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mauritius Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Overview |
3.1 Mauritius Country Macro Economic Indicators |
3.2 Mauritius Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, 2021 & 2031F |
3.3 Mauritius Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market - Industry Life Cycle |
3.4 Mauritius Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market - Porter's Five Forces |
3.5 Mauritius Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Mauritius Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.7 Mauritius Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
4 Mauritius Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of obesity, type II diabetes, and NASH in Mauritius |
4.2.2 Growing awareness about the benefits of endoscopy devices for these conditions |
4.2.3 Technological advancements in endoscopy devices for better diagnosis and treatment |
4.3 Market Restraints |
4.3.1 High cost associated with endoscopy devices and procedures |
4.3.2 Limited reimbursement policies for endoscopic treatments in Mauritius |
4.3.3 Lack of skilled healthcare professionals proficient in using endoscopy devices for these specific conditions |
5 Mauritius Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Trends |
6 Mauritius Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, By Types |
6.1 Mauritius Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Mauritius Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Product, 2021 - 2031F |
6.1.3 Mauritius Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Endoscope, 2021 - 2031F |
6.1.4 Mauritius Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Mechanical endoscopic equipment, 2021 - 2031F |
6.1.5 Mauritius Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Visualization and documentation systems, 2021 - 2031F |
6.1.6 Mauritius Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Accessories, 2021 - 2031F |
6.1.7 Mauritius Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Other endoscopy equipment , 2021 - 2031F |
6.2 Mauritius Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, By Procedure |
6.2.1 Overview and Analysis |
6.2.2 Mauritius Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Gastric balloon, 2021 - 2031F |
6.2.3 Mauritius Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Aspiration therapy, 2021 - 2031F |
6.2.4 Mauritius Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Endoscopic sleeve gastroplasty, 2021 - 2031F |
6.2.5 Mauritius Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Gastric injection, 2021 - 2031F |
6.2.6 Mauritius Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Lap band surgery , 2021 - 2031F |
6.3 Mauritius Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, By Disease Indication |
6.3.1 Overview and Analysis |
6.3.2 Mauritius Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Obesity , 2021 - 2031F |
6.3.3 Mauritius Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Type II Diabetes , 2021 - 2031F |
6.3.4 Mauritius Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Nonalcoholic Steatohepatitis (NASH, 2021 - 2031F |
7 Mauritius Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Import-Export Trade Statistics |
7.1 Mauritius Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Export to Major Countries |
7.2 Mauritius Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Imports from Major Countries |
8 Mauritius Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Key Performance Indicators |
8.1 Average procedure time for endoscopy devices in treating obesity, type II diabetes, and NASH |
8.2 Patient satisfaction rates post-endoscopy procedures |
8.3 Rate of adoption of new endoscopy technologies in the market |
8.4 Number of endoscopy procedures conducted annually for obesity, type II diabetes, and NASH |
8.5 Percentage of successful treatment outcomes using endoscopy devices |
9 Mauritius Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market - Opportunity Assessment |
9.1 Mauritius Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Mauritius Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Opportunity Assessment, By Procedure, 2021 & 2031F |
9.3 Mauritius Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
10 Mauritius Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market - Competitive Landscape |
10.1 Mauritius Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenue Share, By Companies, 2024 |
10.2 Mauritius Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |